BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14318883)

  • 1. [MAST CELLS OF THE SKIN IN ARTERIOSCLEROSIS OBLITERANS OF LOWER EXTREMITIES AND BUERGER'S DISEASE].
    WRZOLKOWA T
    Patol Pol; 1964; 15():445-50. PubMed ID: 14318883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with the treatment of Buerger's disease and obliterating arteriosclerosis of the lower extremities].
    ZAPLETAL B; FISCHER J; VELCL B
    Rozhl Chir; 1952; 31(3-5):127-38. PubMed ID: 13004884
    [No Abstract]   [Full Text] [Related]  

  • 3. THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE).
    ABRAMSON DI
    Heart Bull; 1964; 13():48-51. PubMed ID: 14146982
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the differential diagnosis of Buerger's disease and arteriosclerotic changes of the vessels of the lower extremity].
    IANKOV I; BAEV S
    Khirurgiia (Sofiia); 1962; 15():974-5. PubMed ID: 13956077
    [No Abstract]   [Full Text] [Related]  

  • 5. Buerger's disease (thromboangiitis obliterans): an analysis of the arteriograms of 119 cases.
    Suzuki S; Mine H; Umehara I; Yoshida T; Okada Y
    Clin Radiol; 1982 Mar; 33(2):235-40. PubMed ID: 7067357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T; Atsumi T
    Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE DIAGNOSTIC PROBLEM OF BUERGER'S DISEASE. CRITICAL ANALYSIS WITH CASUISTIC REFERENCES].
    COTTI L; VIGLIERCHIO P
    Minerva Med; 1964 Apr; 55():1301-22. PubMed ID: 14163205
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arteriosclerosis obliterans and Buerger's disease].
    Ishimaru S; Yao Y
    Ryoikibetsu Shokogun Shirizu; 1996; (14):553-6. PubMed ID: 9047930
    [No Abstract]   [Full Text] [Related]  

  • 10. A reconsideration of the pathogenesis of Buerger's disease.
    GORE I; BURROWS S
    Am J Clin Pathol; 1958 Apr; 29(4):319-30. PubMed ID: 13533321
    [No Abstract]   [Full Text] [Related]  

  • 11. [PATHOGENESIS AND ROENTGENOLOGICAL PICTURE OF CHRONIC OBLITERATING PROCESSES IN THE BLOOD VESSELS OF THE LOWER EXTREMITIES].
    SKATULA L
    Cesk Rentgenol; 1964 May; 18():151-60. PubMed ID: 14158979
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of microcirculation in Buerger's disease using 201thallium/99mtechnetium macroaggregated albumin scintigraphy.
    Ateş A; Varoğlu E; Yekeler I; Ozyazicioğlu A
    J Int Med Res; 2002; 30(4):438-41. PubMed ID: 12235928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CONTRIBUTION TO THE KNOWLEDGE OF THE PHLEBOGRAPHIC ASPECT OF THE LOWER EXTREMITIES IN PERIPHERAL ENDARTERIOPATHY].
    GHEZZI C; DE-FERRARI U
    Rass Clin Sci; 1963 Dec; 39():347-52. PubMed ID: 14116054
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE VALUE OF ELECTROMYOGRAPHY FOR THE DIFFERENTIAL DIAGNOSIS OF OBLITERATING ENDARTERITIS OF THE LOWER EXTREMITIES].
    IANDA V; KOZAK P
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():1784-8. PubMed ID: 14189565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Buerger's disease and obliterative atherosclerosis. 2 different diseases].
    Puchmayer V; Pokorný J; Krcílek A
    Cas Lek Cesk; 1986 Oct; 125(43):1313-6. PubMed ID: 3508732
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sympathoplegic therapy of Buerger's disease].
    SOLTESZ L; BOROCZ L; SZABO I
    Magy Belorv Arch (1955); 1957; 10(5-6):138-41. PubMed ID: 13526499
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.
    Sato T; Tamai H; Kobayashi M; Yamamoto K; Komori K
    Cardiovasc Pathol; 2011; 20(5):266-71. PubMed ID: 20708412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CHANCES OF SUCCESS IN THE TREATMENT OF ARTERIAL OCCLUSION OF THE LOWER EXTREMITIES BY SYMPATHECTOMY AND RECONSTRUCTIVE INTERVENTIONS ON THE VASCULAR SYSTEM].
    KUHLGATZ G
    Z Arztl Fortbild (Jena); 1964 Jan; 58():70-4. PubMed ID: 14125777
    [No Abstract]   [Full Text] [Related]  

  • 19. The differential diagnosis and treatment of Buerger's disease and peripheral arteriosclerosis.
    ROSENFELD I
    McGill Med J; 1950 Dec; 19(4):218-27. PubMed ID: 14795896
    [No Abstract]   [Full Text] [Related]  

  • 20. Buerger's disease reassessed.
    Eastcott HH
    Lancet; 1969 Jan; 1(7587):200-1. PubMed ID: 4178437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.